Skip to content

The Role of Radial Peripapillary Vessel Density in Irvine-gass Syndrome

Radial Peripapillary Vessel Density as a New Biomarker in Irvine-Gass Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06436170
Acronym
OCTA and PMCE
Enrollment
30
Registered
2024-05-30
Start date
2023-07-01
Completion date
2024-04-29
Last updated
2024-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Macular Edema

Keywords

OCTA;RPC; IGS;PCME

Brief summary

Pseudophakic cystoid macular edema (PCME), also known as Irvine-Gass syndrome (IGS), is an accumulation of fluid in the macula that occurs after cataract surgery, with an early or late presentation (cut-off 3 months) . It is the most common cause of decreased vision after uneventful phacoemulsification, with a rare incidence of 0.1-2.35% for clinically significant PCME . Macular edema in IGS can be diagnosed and classified by optical coherence tomography (OCT), which enables its morphologic assessment. Fluorescein angiography (FA) is the gold standard to perform differential diagnosis for macular edema. To date, OCT angiography (OCTA) has been proposed to study various retinal vascular diseases. In contrast to FA, OCTA is able to visualize Radial peripapillary vessel density (RCP). The aim of this study was to investigate abnormalities in the vascular network of the optic nerve head in patients with IGS compared to healthy eyes, using OCT-A

Interventions

DIAGNOSTIC_TESTOCTA

OCTA is a non invasive diagnostic technique to visualize RPC

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
58 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

Clinical diagnosis of PCME Cataract surgery

Exclusion criteria

diabetes vein occlusion uveitis vasculitis age-related macular degeneration hereditary macular dystrophy \-

Design outcomes

Primary

MeasureTime frameDescription
the role of OCTA in diagnosis of IGS10 monthsTo evaluate the vascolarization of RPC in IGS

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026